Ex Vivo Results From HIV Positive Individuals With And Without Depression

Infection with human immunodeficiency virus (HIV), which leads to acquired immunodeficiency syndrome (AIDS), is an epidemic of global concern. According to the most recent estimates, released in November 2007, by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO), an estimated 33.

Results Of Brodmann Area 25 Deep Brain Stimulation Pilot Study Offer Hope For Patients With Severe Depression

St. Jude Medical, Inc. (NYSE:STJ) announced pilot study results from the first multi-center study investigating deep brain stimulation (DBS) of Brodmann Area 25 for major depressive disorder. Results of the study, which were presented at the American Psychiatric Association (APA) meeting in Washington, D.

Study Demonstrates Lexapro R Significantly Improves Depression Symptoms In Adolescents

Forest Laboratories, Inc. (NYSE: FRX) announced that study results show Lexapro (escitalopram oxalate) significantly improved symptoms of depression as compared to placebo treatment and was well tolerated in adolescents, aged 12-17, with major depressive disorder (MDD), according to phase III data presented at the 2008 Annual Meeting of the American Psychiatric Association.

Biovail Receives FDA Approval For Aplenzin BVF-033 For The Treatment Of Depression

Biovail Corporation (NYSE: BVF) (TSX: BVF) announced that it has received Approval from the United States Food and Drug Administration (FDA) for its New Drug Application (NDA) for Aplenzin™ (formerly known as BVF-033), a once-daily formulation of bupropion hydrobromide developed by Biovail for the treatment of depression in adults.

According To Research From The University Of Navarra, Smokers Have A 41 Higher Risk Of Suffering Depression

The risk of suffering depression increases 41% in smokers, in comparison with non-smokers. This was the conclusion of a study undertaken with 8, 556 participants by scientists of the University of Navarra, in collaboration with the University of Las Palmas de Gran Canaria and the Harvard School of Public Health (USA), and which demonstrates, in a pioneering way, the direct relationship between tobacco use and this disease.

Study Shows Depression And Anxiety Widespread In Young Tibetan Refugees

A new study led by Emory University School of Medicine researcher Charles L. Raison, MD, is the first to show that depression and anxiety are more prevalent in Tibetan refugees than they are in ethnic Tibetans born and raised in the comparative stability of exile communities in Northern India and Nepal.

Having A Baby Isn't Blissful For All New Mothers

For many women, the lovely images of life with a new baby don't jive with their reality. Instead of feeling happy, they feel overwhelmed.University of New Hampshire researcher Kathleen Kendall-Tackett says there are a myriad of treatments available to new mothers experiencing postpartum depression.

Extending Life By Tackling Depression In Cancer Patients

A study recommended by David Spiegel of Faculty of 1000 Medicine (http://www.f1000medicine.com/), looks at the relationship between depression care management and survival rates in older patients.

How To Recognize The Signs And Symptoms Of Anxiety And Depressive Illnesses

Each year more than 40 million Americans will suffer from an anxiety disorder and more than 19 million Americans will suffer with a depressive illness. The most common signs of anxiety and depression include feelings of being down or blue, phobias, uncontrollable worrying, poor concentration, loss of pleasure, sleeping problems, panic attacks, unexplainable aches, pains or headaches, obsessions, rituals and ongoing feelings of nervousness or tension.

St. Jude Medical Awarded U.S. Patent For Neurostimulation Therapy For Depression

St. Jude Medical, Inc. (NYSE:STJ) announced it has been awarded a patent from the U.S. Patent and Trademark Office for treating depression using neurostimulation therapy in an area of the brain known as Brodmann Area 25. Brodmann Area 25 is a structure within the subcollosal gyrus region of the brain.